Amanda Psyrri
National and Kapodistrian University of Athens
H-index: 62
Europe-Greece
Top articles of Amanda Psyrri
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Human Papilloma Virus (HPV) driven oropharyngeal cancer in current or previous heavy smokers: should we look for a different treatment paradigm? | Frontiers in Oncology | Luigi Lorini Paolo Bossi Amanda Psyrri Pierluigi Bonomo | 2024 |
197MO Final outcome, immunophenotypic and biomarker analysis of intercalated avelumab plus platinum-based chemotherapy in patients with extensive-stage small cell lung cancer … | ESMO Open | G Mountzios K Papadopoulou N Korfiatis A Goussia E Samantas | 2024/3/1 |
Essential data variables for a minimum dataset for head and neck cancer trials and clinical research: HNCIG consensus recommendations and database | European Journal of Cancer | Sujith Baliga Ahmad K Abou-Foul Pablo Parente Petr Szturz Juliette Thariat | 2024/5/1 |
Ten-year clinical outcome, toxicity and compliance of dose-dense sequential adjuvant administration of cyclophosphamide & epirubicin followed by docetaxel in patients with … | The Breast | Foteinos-Ioannis Dimitrakopoulos Anna Goussia Georgia-Angeliki Koliou Katerina Dadouli Anna Batistatou | 2024/2/1 |
Well-differentiated liposarcomas and dedifferentiated liposarcomas: Systemic treatment options for two sibling neoplasms | A Kyriazoglou A Pagkali I Kotsantis P Economopoulou M Kyrkasiadou | 2024/3/11 | |
Detection of hotspot PIK3CA mutations in primary tumors and plasma-cfDNA of breast cancer patients using a novel highly sensitive CE-IVD kit | Cancer Research | Stavroula Smilkou Dimitra Stergiopoulou Eleni Tzanikou Loukas Kaklamanis Ioanna Balgkouranidou | 2024/3/22 |
Real-world data on the safety and efficacy of trastuzumab deruxtecan and sacituzumab govitecan in patients with advanced breast cancer: the experience of the Hellenic … | European Journal of Cancer | E Fountzilas T Lalla G Karakatsoulis K Papazisis K Exarchos | 2024/3/1 |
Is osimertinib effective as 2nd line treatment in T790M-negative EGFR mutant NSCLC? | AME Clinical Trials Review | Panagiota Economopoulou Ioannis Kotsantis Amanda Psyrri | 2024/4/25 |
Clinical trial endpoint use and definitions in curative-intent trials for mucosal head and neck squamous cell carcinomas: HNCIG international consensus recommendations. | The Lancet Oncology | Annette M Lim Lachlan McDowell Chris Hurt Christophe Le Tourneau Akihiro Homma | 2024/1/26 |
Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinoma | Cancer Immunology, Immunotherapy | Tanguy Y Seiwert Sophie Wildsmith Jérôme Fayette Kevin Harrington Maura Gillison | 2024/3/2 |
An algorithm for standardization of tumor Infiltrating lymphocyte evaluation in head and neck cancers | Oral Oncology | Vasiliki Xirou Myrto Moutafi Yalai Bai Thazin Nwe Aung Sneha Burela | 2024/5/1 |
113P Real-world data from patients with osteosarcoma treated in 4 medical centers in Greece: Ninety percent or greater tumor necrosis is associated with disease-free survival | ESMO Open | M Moutafi A Kyriazoglou I Kotsantis S Kokkali-Zervos P Antonopoulou | 2024/3/1 |
Detection of PD-L1 mRNA expression in circulating tumor cells (CTCs) from patients with metastatic NSCLC, HNSCC and melanoma using a novel highly sensitive … | Cancer Research | Areti Strati Martha Zavridou Stavroula Smilkou Victoria Tserpeli Eleni Tzanikou | 2024/3/22 |
B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma | Annals of Oncology | Niki Gavrielatou Ekaterina Fortis Aris Spathis Maria Anastasiou Panagiota Economopoulou | 2023/12/28 |
Spatial characterization and quantification of CD40 expression across cancer types | BMC cancer | Katherine M Bates Ioannis Vathiotis Tyler MacNeil Fahad Shabbir Ahmed Thazin Nwe Aung | 2023/3/9 |
Digital spatial profiling links beta-2-microglobulin expression with immune checkpoint blockade outcomes in head and neck squamous cell carcinoma | Cancer Research Communications | Niki Gavrielatou Ioannis Vathiotis Thazin Nwe Aung Saba Shafi Sneha Burela | 2023/4/11 |
Investigation of Clinically Significant Molecular Aberrations in Patients with Prostate Cancer: Implications for Personalized Treatment, Prognosis and Genetic Testing | International Journal of Molecular Sciences | Elena Fountzilas Maria Kouspou Alexia Eliades Kyriaki Papadopoulou Evangelos Bournakis | 2023/7/23 |
854O INTERLINK-1: Phase III study of cetuximab (CTX)±monalizumab (M) in participants (pts) with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC) with … | Annals of Oncology | J Fayette LFL Licitra KJ Harrington R Haddad LL Siu | 2023/10/1 |
MA01. 03 Thromboprophylaxis for Lung Cancer Patients: Combined Results from GMaT and ACT4CAT Studies | Journal of Thoracic Oncology | NG Tsoukalas A Christopoulou E Timotheadou A Koumarianou A Ardavanis | 2023/11/1 |
106P Treatment sequencing in PD-L1–positive recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Exploratory analysis of the phase III KEYNOTE-048 study | Immuno-Oncology and Technology | R Greil B Burtness S Laban I Braña R Mesia Nin | 2023/12/1 |
